Nixar (Bilastine)

Bilastine selectively blocks peripheral H1 receptors on ocular mast cells and conjunctival tissues. By preventing histamine from binding, it stops the cascade that leads to vasodilation, increased vascular permeability and nerve activation, thereby reducing inflammation and discomfort in the eye.

The prescribed dose is determined by the treating clinician. In typical practice, one drop is instilled into each affected eye once daily, but the exact regimen must follow the healthcare professional’s instructions and the product label.

Safety data for bilastine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

Enquiries can be submitted through the product page on gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Bilastine is a second‑generation H1 antagonist, offering a lower risk of sedation compared with first‑generation agents. Its high selectivity provides effective relief of allergic eye symptoms while minimizing systemic exposure, making it a preferred option for patients needing once‑daily dosing.

Store Nixar at room temperature, below 25 °C, in the original packaging. Protect the container from direct sunlight, moisture and extreme temperatures. Keep out of reach of children and do not use the product after the expiration date.

Nixar is applied topically to the eye. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place the prescribed number of drops into the conjunctival sac. Close the eye gently for a few seconds to allow distribution.

Although rare, serious adverse events include severe allergic reactions such as anaphylaxis, a marked increase in intra‑ocular pressure, persistent eye pain, sudden vision changes, and significant ocular edema. Any of these symptoms require immediate medical attention.

Nixar should not be used by individuals with a known hypersensitivity to bilastine or any of the formulation’s excipients. Caution is advised in patients with severe hepatic impairment, and it should be avoided in those who have experienced severe ocular reactions to other antihistamine eye drops.